BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 27149079)

  • 1. Behavioral functioning in cardiofaciocutaneous syndrome: Risk factors and impact on parenting experience.
    Pierpont EI; Wolford M
    Am J Med Genet A; 2016 Aug; 170(8):1974-88. PubMed ID: 27149079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial cardiofaciocutaneous syndrome in a father and a son with a novel MEK2 mutation.
    Karaer K; Lissewski C; Zenker M
    Am J Med Genet A; 2015 Feb; 167A(2):385-8. PubMed ID: 25487361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variability in clinical and neuropsychological features of individuals with MAP2K1 mutations.
    Pierpont EI; Semrud-Clikeman M; Pierpont ME
    Am J Med Genet A; 2017 Feb; 173(2):452-459. PubMed ID: 27862862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A sibling pair with cardiofaciocutaneous syndrome (CFC) secondary to BRAF mutation with unaffected parents-the first cases of gonadal mosaicism in CFC?
    Geoghegan S; King G; Henchliffe J; Ramsden SC; Barry RJ; Green AJ; O'Connell SM
    Am J Med Genet A; 2018 Jul; 176(7):1637-1640. PubMed ID: 29704308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The perinatal presentation of cardiofaciocutaneous syndrome.
    Wong Ramsey KN; Loichinger MH; Slavin TP; Kuo S; Seaver LH
    Am J Med Genet A; 2014 Aug; 164A(8):2036-42. PubMed ID: 24719372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Mutagenic effect of advanced paternal age in neurocardiofaciocutaneous syndrome].
    Seemanová E; Zenker M
    Cas Lek Cesk; 2014; 153(5):242-5. PubMed ID: 25370770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lymphatic phenotype in Noonan and Cardiofaciocutaneous syndrome.
    Joyce S; Gordon K; Brice G; Ostergaard P; Nagaraja R; Short J; Moore S; Mortimer P; Mansour S
    Eur J Hum Genet; 2016 May; 24(5):690-6. PubMed ID: 26242988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unusual hair findings in a child with cardiofaciocutaneous syndrome.
    Işikay S; Karaer K
    Int J Dermatol; 2019 Mar; 58(3):354-356. PubMed ID: 30094826
    [No Abstract]   [Full Text] [Related]  

  • 9. Emergence of a Genetic Diagnosis: Case Presentation of a Preterm Infant With Cardiofaciocutaneous Syndrome.
    Anderson S; Brooks SS
    Adv Neonatal Care; 2015 Aug; 15(4):274-84. PubMed ID: 26225596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiofaciocutaneous syndrome and the dermatologist's contribution to diagnosis.
    Rocha VB; Moraes RA; Pereira LB
    Cutis; 2017 Jan; 99(1):E4-E7. PubMed ID: 28207016
    [No Abstract]   [Full Text] [Related]  

  • 11. Cardio-facio-cutaneous syndrome: clinical features, diagnosis, and management guidelines.
    Pierpont ME; Magoulas PL; Adi S; Kavamura MI; Neri G; Noonan J; Pierpont EI; Reinker K; Roberts AE; Shankar S; Sullivan J; Wolford M; Conger B; Santa Cruz M; Rauen KA
    Pediatrics; 2014 Oct; 134(4):e1149-62. PubMed ID: 25180280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CNS imaging is a key diagnostic tool in the evaluation of patients with CFC syndrome: two cases and literature review.
    Papadopoulou E; Sifakis S; Sol-Church K; Klein-Zighelboim E; Stabley DL; Raissaki M; Gripp KW; Kalmanti M
    Am J Med Genet A; 2011 Mar; 155A(3):605-11. PubMed ID: 21337689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anesthetic Management of a Pediatric Patient With Cardiofaciocutaneous Syndrome.
    Shionoya Y; Yamamoto M; Sunada K; Nakamura K
    Anesth Prog; 2020; 67(1):45-47. PubMed ID: 32191511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXI2: a possible gene contributing to ectodermal dysplasia.
    Kurban M; Zeineddine SB; Hamie L; Safi R; Abbas O; Kibbi AG; Bitar F; Nemer G
    Eur J Dermatol; 2017 Dec; 27(6):641-645. PubMed ID: 29165300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiofaciocutaneous syndrome with KRAS gene mutation presenting as chylopericardium.
    Akahoshi S; Hirano A; Nagamine H; Miura M
    Am J Med Genet A; 2020 Mar; 182(3):532-535. PubMed ID: 31926049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular characterization of children with Noonan syndrome and other RASopathies in Argentina.
    Chinton J; Huckstadt V; Moresco A; Gravina LP; Obregon MG
    Arch Argent Pediatr; 2019 Oct; 117(5):330-337. PubMed ID: 31560489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-hodgkin lymphoma in a patient with cardiofaciocutaneous syndrome.
    Ohtake A; Aoki Y; Saito Y; Niihori T; Shibuya A; Kure S; Matsubara Y
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):e342-6. PubMed ID: 20523244
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Objective studies of the face of Noonan, Cardio-facio-cutaneous, and Costello syndromes: A comparison of three disorders of the Ras/MAPK signaling pathway.
    Allanson JE
    Am J Med Genet A; 2016 Oct; 170(10):2570-7. PubMed ID: 27155212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cardiofaciocutaneous syndrome, a Noonan syndrome related disorder: clinical and molecular findings in 11 patients].
    Carcavilla A; García-Miñaúr S; Pérez-Aytés A; Vendrell T; Pinto I; Guillén-Navarro E; González-Meneses A; Aoki Y; Grinberg D; Ezquieta B
    Med Clin (Barc); 2015 Jan; 144(2):67-72. PubMed ID: 25194980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perinatal features of the RASopathies: Noonan syndrome, cardiofaciocutaneous syndrome and Costello syndrome.
    Myers A; Bernstein JA; Brennan ML; Curry C; Esplin ED; Fisher J; Homeyer M; Manning MA; Muller EA; Niemi AK; Seaver LH; Hintz SR; Hudgins L
    Am J Med Genet A; 2014 Nov; 164A(11):2814-21. PubMed ID: 25250515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.